1. Home
  2. IMG vs ZBIO Comparison

IMG vs ZBIO Comparison

Compare IMG & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMG
  • ZBIO
  • Stock Information
  • Founded
  • IMG 2011
  • ZBIO 2019
  • Country
  • IMG Hong Kong
  • ZBIO United States
  • Employees
  • IMG N/A
  • ZBIO N/A
  • Industry
  • IMG
  • ZBIO
  • Sector
  • IMG
  • ZBIO
  • Exchange
  • IMG NYSE
  • ZBIO NYSE
  • Market Cap
  • IMG 14.7M
  • ZBIO 389.2M
  • IPO Year
  • IMG 2020
  • ZBIO 2024
  • Fundamental
  • Price
  • IMG $0.26
  • ZBIO $12.15
  • Analyst Decision
  • IMG
  • ZBIO Strong Buy
  • Analyst Count
  • IMG 0
  • ZBIO 7
  • Target Price
  • IMG N/A
  • ZBIO $32.29
  • AVG Volume (30 Days)
  • IMG 1.5M
  • ZBIO 189.4K
  • Earning Date
  • IMG 08-18-2025
  • ZBIO 08-16-2025
  • Dividend Yield
  • IMG N/A
  • ZBIO N/A
  • EPS Growth
  • IMG N/A
  • ZBIO N/A
  • EPS
  • IMG N/A
  • ZBIO N/A
  • Revenue
  • IMG $3,785,663.00
  • ZBIO $15,000,000.00
  • Revenue This Year
  • IMG $99.05
  • ZBIO $165.20
  • Revenue Next Year
  • IMG $130.30
  • ZBIO $63.75
  • P/E Ratio
  • IMG N/A
  • ZBIO N/A
  • Revenue Growth
  • IMG 109.62
  • ZBIO N/A
  • 52 Week Low
  • IMG $0.23
  • ZBIO $5.83
  • 52 Week High
  • IMG $8.00
  • ZBIO $26.25
  • Technical
  • Relative Strength Index (RSI)
  • IMG N/A
  • ZBIO N/A
  • Support Level
  • IMG N/A
  • ZBIO N/A
  • Resistance Level
  • IMG N/A
  • ZBIO N/A
  • Average True Range (ATR)
  • IMG 0.00
  • ZBIO 0.00
  • MACD
  • IMG 0.00
  • ZBIO 0.00
  • Stochastic Oscillator
  • IMG 0.00
  • ZBIO 0.00

About IMG CIMG INC

CIMG Inc is a coffee and technologies company. The company is a co-packer of single-serve pour-over coffee, coffee brew bags and Dripkits. The company's brand portfolio includes Coffee Blenders, Twin Peaks, Active Cup, Relax Cup, Think Cup, Nude Cup, Pine Ranch Coffee, and Dripkit. Its geographical segments are North America, which accounts for the majority of revenue; and South Korea.

About ZBIO ZENAS BIOPHARMA INC

Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.

Share on Social Networks: